Unraveling the enigma: A comprehensive review of solid pseudopapillary tumor of the pancreas

World J Gastrointest Oncol. 2024 Mar 15;16(3):614-629. doi: 10.4251/wjgo.v16.i3.614.

Abstract

Solid pseudopapillary tumor of the pancreas (SPTP) is a rare neoplasm predominantly observed in young females. Pathologically, CTNNB1 mutations, β-catenin nuclear accumulation, and subsequent Wnt-signaling pathway activation are the leading molecular features. Accurate preoperative diagnosis often relies on imaging techniques and endoscopic biopsies. Surgical resection remains the mainstay treatment. Risk models, such as the Fudan Prognostic Index, show promise as predictive tools for assessing the prognosis of SPTP. Establishing three types of metachronous liver metastasis can be beneficial in tailoring individualized treatment and follow-up strategies. Despite advancements, challenges persist in understanding its etiology, establishing standardized treatments for unresectable or metastatic diseases, and developing a widely recognized grading system. This comprehensive review aims to elucidate the enigma by consolidating current knowledge on the epidemiology, clinical presentation, pathology, molecular characteristics, diagnostic methods, treatment options, and prognostic factors.

Keywords: Endoscopic ultrasound; Liver metastasis; Pancreas; Prognostic prediction; Recurrence; Solid pseudopapillary tumor; Surgery; β-catenin.

Publication types

  • Review